The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations

Cancer Causes and Control

Volumn 27, Issue 11, 2016, Pages 1315-1323

  Chubak, Jessica ^a   Ziebell, Rebecca ^a   Greenlee, Robert T ^b   Honda, Stacey ^c   Hornbrook, Mark C ^d   Epstein, Mara ^e   Nekhlyudov, Larissa ^f   Pawloski, Pamala A ^g   Ritzwoller, Debra P ^c   Ghai, Nirupa R ^c   Feigelson, Heather Spencer ^c   Clancy, Heather A ^h   Doria Rose, V Paul ⁱ   Kushi, Lawrence H ^h  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b MARSHFIELD CLINIC   (United States)

^c KAISER PERMANENTE   (United States)

^d CENTER FOR HEALTH RESEARCH   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g HEALTHPARTNERS INSTITUTE   (United States)

^h DIVISION OF RESEARCH   (United States)

ⁱ NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Epidemiology; Health services; Integrated health care delivery systems

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER REGISTRY; CANCER RESEARCH; CANCER RISK; CANCER SURVIVAL; ETHNIC DIFFERENCE; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY; HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; NATIONAL HEALTH ORGANIZATION; NEOPLASMS;

DELIVERY OF HEALTH CARE; HEALTH SERVICES RESEARCH; HUMANS; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; UNITED STATES;

EID: 84988443461     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-016-0808-4     Document Type: Article

References (24)

1. Lyman GH, Levine M (2012) Comparative effectiveness research in oncology: an overview. J Clin Oncol. doi:10.1200/JCO.2012.45.9792
2. Carpenter WR, Meyer A-M, Abernethy AP, Sturmer T, Kosorok MR (2012) A framework for understanding cancer comparative effectiveness research data needs. J Clin Epidemiol 65(11):1150–1158. doi:10.1016/j.jclinepi.2012.06.005
3. Abernethy AP, Etheredge LM, Ganz PA, Wallace P, German RR, Neti C, Bach PB, Murphy SB (2010) Rapid-learning system for cancer care. J Clin Oncol 28(27):4268–4274. doi:10.1200/jco.2010.28.5478
4. National Cancer Institute Introduction to PROSPR. U.S. Department of Health and Human Services. http://healthcaredelivery.cancer.gov/prospr/introduction.html. Accessed 20 Nov 2015
5. National Cancer Institute NCI Community Oncology Research Program (NCORP) Home Page. U.S. Department of Health and Human Services. http://ncorp.cancer.gov/about/. Accessed 20 Nov 2015
6. Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM (2005) Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr 35:3–11. doi:10.1093/jncimonographs/lgi032
7. Hornbrook MC, Hart G, Ellis JL, Bachman DJ, Ansell G, Greene SM, Wagner EH, Pardee R, Schmidt MM, Geiger A, Butani AL, Field T, Fouayzi H, Miroshnik I, Liu L, Diseker R, Wells K, Krajenta R, Lamerato L, Neslund Dudas C (2005) Building a virtual cancer research organization. J Natl Cancer Inst Monogr 35:12–25. doi:10.1093/jncimonographs/lgi033
8. Nekhlyudov L, Greene SM, Chubak J, Rabin B, Tuzzio L, Rolnick S, Field TS (2013) Cancer Research Network: using integrated healthcare delivery systems as platforms for cancer survivorship research. J Cancer Surviv 7(1):55–62. doi:10.1007/s11764-012-0244-8
9. Geiger AM, Buist DS, Greene SM, Altschuler A, Field TS (2008) Survivorship research based in integrated healthcare delivery systems: the Cancer Research Network. Cancer 112(11 Suppl):2617–2626. doi:10.1002/cncr.23447
10. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326(10):653–657. doi:10.1056/NEJM199203053261001
11. Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS (2013) Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 158(5 Pt 1):312–320. doi:10.7326/0003-4819-158-5-201303050-00003
12. Geiger AM, Thwin SS, Lash TL, Buist DS, Prout MN, Wei F, Field TS, Ulcickas Yood M, Frost FJ, Enger SM, Silliman RA (2007) Recurrences and second primary breast cancers in older women with initial early-stage disease. Cancer 109(5):966–974
13. Ritzwoller DP, Carroll NM, Delate T, Hornbrook MC, Kushi L, Bowles EJ, Loggers ET, Menter A (2014) Comparative effectiveness of adjunctive bevacizumab for advanced lung cancer: the cancer research network experience. J Thorac Oncol 9(5):692–701. doi:10.1097/JTO.0000000000000127
14. Loggers ET, Fishman PA, Peterson D, O’Keeffe-Rosetti M, Greenberg C, Hornbrook MC, Kushi LH, Lowry S, Ramaprasan A, Wagner EH, Weeks JC, Ritzwoller DP (2014) Advanced imaging among health maintenance organization enrollees with cancer. J Oncol Pract 10(4):231–238. doi:10.1200/JOP.2013.001258
15. Bowles EJA, Wellman R, Feigelson HS, Onitilo AA, Freedman AN, Delate T, Allen LA, Nekhlyudov L, Goddard KAB, Davis RL, Habel LA, Yood MU, Mccarty C, Magid DJ, Wagner EH, Pharmacovigilance Study Team (2012) Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Nat Cancer Inst 104(17):1293–1305. doi:10.1093/jnci/djs317
16. Prouty CD, Mazor KM, Greene SM, Roblin DW, Firneno CL, Lemay CA, Robinson BE, Gallagher TH (2014) Providers’ perceptions of communication breakdowns in cancer care. J Gen Intern Med 29(8):1122–1130. doi:10.1007/s11606-014-2769-1
17. Geiger AM, Castellino SM, Tooze JA, Altschuler A, Month S, Mertens AC, Nekhlyudov L, Greene SM (2013) Potential role of community-based healthcare system data in research on survivors of adolescent and young adult cancer. J Adolesc Young Adult Oncol 2(2):53–58. doi:10.1089/jayao.2012.0033
18. Ross TR, Ng D, Brown JS, Pardee R, Hornbrook MC (2014) The HMO Research Network Virtual Data Warehouse: A Public Data Model to Support Collaboration. EGEMS (Wash DC) 2 (1):Article 2. doi: 10.13063/2327-9214.1049
19. Surveillance Epidemiology and End Results (SEER) Program Site Recode ICD-O-3/WHO 2008 Definition. U.S. Department of Health and Human Services. http://seer.cancer.gov/siterecode/icdo3_dwhoheme/index.html. Accessed 5 Jan 2015
20. Field TS, Cernieux J, Buist D, Geiger A, Lamerato L, Hart G, Bachman D, Krajenta R, Greene S, Hornbrook MC, Ansell G, Herrinton L, Reed G (2004) Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network. J Natl Cancer Inst 96(2):148–152
21. Surveillance Epidemiology and End Results Table 1.5 Age-Adjusted SEER Incidence and U.S. Death Rates and 5-Year Relative Survival (Percent) By Primary Cancer Site, Sex and Time Period. National Cancer Institute. http://seer.cancer.gov/csr/1975_2012/results_merged/topic_survival.pdf. Accessed 10 July 2015
22. Boudreau DM, Yu O, Miglioretti DL, Buist DSM, Heckbert SR, Daling JR (2007) Statin use and breast cancer risk in a large population-based setting. Cancer Epidemiol Biomarkers Prev 16(3):416–421. doi:10.1158/1055-9965.epi-06-0737
23. Clough-Gorr KM, Thwin SS, Bosco JLF, Silliman RA, Buist DSM, Pawloski PA, Quinn VP, Prout MN (2012) Incident malignancies among older long-term breast cancer survivors and an age-matched and site-matched nonbreast cancer comparison group over 10 years of follow-up. Cancer 119(8):1478–1485. doi:10.1002/cncr.27914
24. Buist DS, Bosco JL, Silliman RA, Gold HT, Field T, Yood MU, Quinn VP, Prout M, Lash TL, Breast Cancer Outcomes in Older Women Investigators (2013) Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer. Breast Cancer Res Treat 142(1):153–163. doi:10.1007/s10549-013-2720-x